Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lactobacillus reuteri MJM60668 Prevent Progression of Non-Alcoholic Fatty Liver Disease through Anti-Adipogenesis and Anti-Inflammatory Pathway
Pia Werlinger, Huong Thi Nguyen, Mingkun Gu, et al.
Microorganisms (2022) Vol. 10, Iss. 11, pp. 2203-2203
Open Access | Times Cited: 17

Showing 17 citing articles:

NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options
Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 366-366
Open Access | Times Cited: 18
From probiotics to postbiotics: Concepts and applications
Hongmei Chen, Ning Ma, Yue Feng, et al.
Animal Research and One Health (2023) Vol. 1, Iss. 1, pp. 92-114
Open Access | Times Cited: 34
Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies
Muthukumaran Jayachandran, Shen Qu
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 6, pp. 1189-1204
Closed Access | Times Cited: 26
Emerging insights into the gut microbiota as a key regulator of immunity and response to immunotherapy in hepatocellular carcinoma
Siqi Ren, Yinping Zhang, Xingyue Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Anti-obesity potential of chickpea fermented by Lactiplantibacillus sp. (PMS-A6) from salted oyster: UPLC-ESI-Q-TOF-MSE profiling and in-vitro/in-vivo validation
Harshavardhan Mohan, Pavithra Muthukumar Sathya, Shweta S Acharya, et al.
Food Research International (2025), pp. 116133-116133
Closed Access
Lactobacillus reuteri in digestive system diseases: focus on clinical trials and mechanisms
Yijing Peng, Yizhe Ma, Zichen Luo, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 12
Impact of Lactobacillaceae supplementation on the multi-organ axis during MASLD
André A. Santos, Raquel Duarte, Madalena Duarte, et al.
Life Sciences (2024) Vol. 354, pp. 122948-122948
Open Access | Times Cited: 4
Probiotics and Non-Alcoholic Fatty Liver Disease: Unveiling the Mechanisms of Lactobacillus plantarum and Bifidobacterium bifidum in Modulating Lipid Metabolism, Inflammation, and Intestinal Barrier Integrity
Jing Lu, Dilireba Shataer, Huizhen Yan, et al.
Foods (2024) Vol. 13, Iss. 18, pp. 2992-2992
Open Access | Times Cited: 4
Association of Short‐Chain Fatty Acids with Gut Microbiota and Lipid Metabolism in Mice with Diarrhea Induced by High‐Fat Diet in a Fatigued State
Bo Qiao, Jing Liu, Xinxin Peng, et al.
Molecular Nutrition & Food Research (2023) Vol. 67, Iss. 18
Closed Access | Times Cited: 9
Effects of probiotic supplementation on testosterone levels in healthy ageing men: A 12-week double-blind, placebo-controlled randomized clinical trial
Lennart Ljunggren, E. I. Butler, Jakob Axelsson, et al.
Contemporary Clinical Trials Communications (2024) Vol. 39, pp. 101300-101300
Open Access | Times Cited: 2
Probiotics as Potential Therapy in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD)
Margalida Monserrat-Mesquida, Cristina Bouzas, Catalina M. Mascaró, et al.
Fermentation (2023) Vol. 9, Iss. 4, pp. 395-395
Open Access | Times Cited: 4
Roles of gut microbes in metabolic-associated fatty liver disease
Chun‐Yao Chen, Han‐Chen Ho
Tzu Chi Medical Journal (2023)
Open Access | Times Cited: 2
PIK3CA mutations enhance the adipogenesis of ADSCs in facial infiltrating lipomatosis through TRPV1
Hongrui Chen, Bin Sun, Wei Gao, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110467-110467
Open Access
Therapeutic Role of Probiotics Against Environmental-Induced Hepatotoxicity: Mechanisms, Clinical Perspectives, Limitations, and Future
Shehzeen Noor, Shaukat Ali, Muhammad Summer, et al.
Probiotics and Antimicrobial Proteins (2024)
Closed Access
Characterization of Human Breast Milk-Derived Limosilactobacillus reuteri MBHC 10138 with Respect to Purine Degradation, Anti-Biofilm, and Anti-Lipid Accumulation Activities
Jinhua Cheng, Joo‐Hyung Cho, Joo‐Won Suh
Antibiotics (2024) Vol. 13, Iss. 10, pp. 964-964
Open Access
The role of probiotics in the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD): new insights based on meta-analysis and subgroup analysis
M. Xiao, Yang Cao, Linlin Wang, et al.
Food Bioscience (2024) Vol. 62, pp. 105454-105454
Closed Access
Diet-induced impairment of skeletal muscle and adipose tissue metabolic homeostasis and its prevention by probiotic administration
Angela Di Porzio, Valentina Barrella, Luisa Cigliano, et al.
Pflügers Archiv - European Journal of Physiology (2024)
Closed Access
Effects of Probiotics on Liver Diseases: Current In Vitro and In Vivo Studies
Maryam Sadri, Zahra Shafaghat, Mona Roozbehani, et al.
Probiotics and Antimicrobial Proteins (2024)
Closed Access
Page 1

Scroll to top